- Home
- CLNN vs OSRH Comparison
CLNN vs OSRH Comparison
Compare CLNN & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLNN
- OSRH
- Stock Information
- Founded
- CLNN 2012
- OSRH N/A
- Country
- CLNN United States
- OSRH United States
- Employees
- CLNN N/A
- OSRH N/A
- Industry
- CLNN Biotechnology: Pharmaceutical Preparations
- OSRH
- Sector
- CLNN Health Care
- OSRH
- Exchange
- CLNN Nasdaq
- OSRH Nasdaq
- Market Cap
- CLNN 23.1M
- OSRH 26.3M
- IPO Year
- CLNN N/A
- OSRH N/A
- Fundamental
- Price
- CLNN $3.70
- OSRH $1.08
- Analyst Decision
- CLNN Strong Buy
- OSRH
- Analyst Count
- CLNN 5
- OSRH 0
- Target Price
- CLNN $40.00
- OSRH N/A
- AVG Volume (30 Days)
- CLNN 56.5K
- OSRH 209.6K
- Earning Date
- CLNN 08-06-2025
- OSRH 08-24-2025
- Dividend Yield
- CLNN N/A
- OSRH N/A
- EPS Growth
- CLNN N/A
- OSRH N/A
- EPS
- CLNN N/A
- OSRH N/A
- Revenue
- CLNN $350,000.00
- OSRH N/A
- Revenue This Year
- CLNN N/A
- OSRH N/A
- Revenue Next Year
- CLNN $1,753.57
- OSRH N/A
- P/E Ratio
- CLNN N/A
- OSRH N/A
- Revenue Growth
- CLNN N/A
- OSRH N/A
- 52 Week Low
- CLNN $2.28
- OSRH $1.02
- 52 Week High
- CLNN $6.96
- OSRH $13.40
- Technical
- Relative Strength Index (RSI)
- CLNN 46.64
- OSRH N/A
- Support Level
- CLNN $3.53
- OSRH N/A
- Resistance Level
- CLNN $3.81
- OSRH N/A
- Average True Range (ATR)
- CLNN 0.21
- OSRH 0.00
- MACD
- CLNN -0.07
- OSRH 0.00
- Stochastic Oscillator
- CLNN 24.64
- OSRH 0.00
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
About OSRH OSR Holdings Inc. Common Stock
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.